{
  "generated": "2025-11-06T07:07:38.834604+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/metabolic/inositol-meta-gen-0408/metabolic/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "META-GEN-0408_01",
      "year": 2015,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "hba1c",
      "population": "Adults with hba1c concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/inositol-meta-gen-0408-01",
      "url": "https://doi.org/10.1234/inositol-meta-gen-0408-01",
      "citation": "META-GEN-0408_01 (2015); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with hba1c concerns; Outcome: hba1c; DOI: 10.1234/inositol-meta-gen-0408-01; Adverse Events: Transient headache."
    },
    {
      "study_id": "META-GEN-0408_02",
      "year": 2016,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "hba1c",
      "population": "Adults with hba1c concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/inositol-meta-gen-0408-02",
      "url": "https://doi.org/10.1234/inositol-meta-gen-0408-02",
      "citation": "META-GEN-0408_02 (2016); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with hba1c concerns; Outcome: hba1c; DOI: 10.1234/inositol-meta-gen-0408-02; Adverse Events: None reported."
    },
    {
      "study_id": "META-GEN-0408_03",
      "year": 2017,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "hba1c",
      "population": "Adults with hba1c concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/inositol-meta-gen-0408-03",
      "url": "https://doi.org/10.1234/inositol-meta-gen-0408-03",
      "citation": "META-GEN-0408_03 (2017); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with hba1c concerns; Outcome: hba1c; DOI: 10.1234/inositol-meta-gen-0408-03; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/inositol-meta-gen-0408-01",
      "study_ids": [
        "META-GEN-0408_01"
      ],
      "primary_study_id": "META-GEN-0408_01",
      "url": "https://doi.org/10.1234/inositol-meta-gen-0408-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/inositol-meta-gen-0408-02",
      "study_ids": [
        "META-GEN-0408_02"
      ],
      "primary_study_id": "META-GEN-0408_02",
      "url": "https://doi.org/10.1234/inositol-meta-gen-0408-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/inositol-meta-gen-0408-03",
      "study_ids": [
        "META-GEN-0408_03"
      ],
      "primary_study_id": "META-GEN-0408_03",
      "url": "https://doi.org/10.1234/inositol-meta-gen-0408-03"
    }
  ],
  "manifest_hash": "sha256:b8a605e17a7b011926f99acff4a278ef73cad2e02cf78f31e259d220719bb024"
}
